Nyxoah SA (NYXH)
4.60
-0.05
(-1.08%)
USD |
NASDAQ |
Dec 31, 16:00
4.62
+0.02
(+0.43%)
After-Hours: 20:00
Nyxoah EPS Diluted (Quarterly): -0.7359 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Galapagos NV | -3.584 |
| UCB SA | -- |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
| MDxHealth SA | -0.1618 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.55M |
| Revenue (Quarterly) | 2.304M |
| Total Expenses (Quarterly) | 29.86M |
| Enterprise Value | 196.37M |
| Gross Profit Margin (Quarterly) | -12.52% |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -54.00% |
| Normalized Earnings Yield | -54.77 |